116 related articles for article (PubMed ID: 31934017)
1. Z-VRPR-FMK can inhibit the growth and invasiveness of diffuse large B-cell lymphoma by depressing NF-κB activation and MMP expression induced by MALT1.
Feng J; Yang W; Wang J; Pu Z; Han Y; Wan L
Int J Clin Exp Pathol; 2019; 12(6):1947-1955. PubMed ID: 31934017
[TBL] [Abstract][Full Text] [Related]
2. Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 Positively Modulates Matrix Metalloproteinase-9 Production in Alveolar Macrophages upon Toll-Like Receptor 7 Signaling and Influenza Virus Infection.
Lee YH; Huang JH; Chang TH; Yang HC; Wu-Hsieh BA
Front Immunol; 2017; 8():1177. PubMed ID: 29018444
[TBL] [Abstract][Full Text] [Related]
3. Autocleavage of the paracaspase MALT1 at Arg-781 attenuates NF-κB signaling and regulates the growth of activated B-cell like diffuse large B-cell lymphoma cells.
Wu CH; Yang YH; Chen MR; Tsai CH; Cheng AL; Doong SL
PLoS One; 2018; 13(6):e0199779. PubMed ID: 29953499
[TBL] [Abstract][Full Text] [Related]
4. PMA/IONO affects diffuse large B-cell lymphoma cell growth through upregulation of A20 expression.
Yang W; Li Y; Li P; Wang L
Oncol Rep; 2016 Aug; 36(2):1069-75. PubMed ID: 27349720
[TBL] [Abstract][Full Text] [Related]
5. Profiling the activity of the para-caspase MALT1 in B-cell acute lymphoblastic leukemia for potential targeted therapeutic application.
Safa FM; Rasmussen T; Fontan L; Xia M; Melnick A; Wiestner A; Lobelle-Rich P; Burger JA; Mouawad Y; Safah H; Flemington EK; Saba NS
Haematologica; 2024 May; 109(5):1348-1358. PubMed ID: 37767562
[TBL] [Abstract][Full Text] [Related]
6. Abnormal expression of A20 and its regulated genes in peripheral blood from patients with lymphomas.
Wang X; Xu Y; Liang L; Xu Y; Wang C; Wang L; Chen S; Yang L; Wu X; Li B; Luo G; Tan H; Li W; Li Y
Cancer Cell Int; 2014; 14():36. PubMed ID: 24790527
[TBL] [Abstract][Full Text] [Related]
7. Expression and clinical significance of miR-23a and MTSS1 in diffuse large B-cell lymphoma.
Xu M; Xu T
Oncol Lett; 2018 Jul; 16(1):371-377. PubMed ID: 29928423
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia.
Ma Y; Liao Z; Xu Y; Zhong Z; Wang X; Zhang F; Chen S; Yang L; Luo G; Huang X; Huang S; Wu X; Li Y
Eur J Med Res; 2014 Nov; 19(1):62. PubMed ID: 25384343
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of heme oxygenase-1 induced by constitutively activated NF-κB as a potential therapeutic target for activated B-cell-like diffuse large B-cell lymphoma.
Huang J; Guo P; Ma D; Lin X; Fang Q; Wang J
Int J Oncol; 2016 Jul; 49(1):253-64. PubMed ID: 27211510
[TBL] [Abstract][Full Text] [Related]
10. Targeting MALT1 for the treatment of diffuse large B-cell lymphoma.
Seshadri MR; Melnick AM
Leuk Lymphoma; 2022 Apr; 63(4):789-798. PubMed ID: 34783281
[TBL] [Abstract][Full Text] [Related]
11. Peptide-based covalent inhibitors of MALT1 paracaspase.
Hatcher JM; Du G; Fontán L; Us I; Qiao Q; Chennamadhavuni S; Shao J; Wu H; Melnick A; Gray NS; Scott DA
Bioorg Med Chem Lett; 2019 Jun; 29(11):1336-1339. PubMed ID: 30954428
[TBL] [Abstract][Full Text] [Related]
12. The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21).
Kuo SH; Tsai HJ; Lin CW; Yeh KH; Lee HW; Wei MF; Shun CT; Wu MS; Hsu PN; Chen LT; Cheng AL
J Pathol; 2017 Feb; 241(3):420-433. PubMed ID: 27873317
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of MALT1-A20-NF-κB in adult B-cell acute lymphoblastic leukemia.
Xu Y; Hu J; Wang X; Xuan L; Lai J; Xu L; Chen S; Yang L; Luo G; Zhu K; Wu X; Li Y
Cancer Cell Int; 2015; 15():73. PubMed ID: 26213496
[TBL] [Abstract][Full Text] [Related]
14. Post-translational Modifications of the CARMA1-BCL10-MALT1 Complex in Lymphocytes and Activated B-Cell Like Subtype of Diffuse Large B-Cell Lymphoma.
Thys A; Douanne T; Bidère N
Front Oncol; 2018; 8():498. PubMed ID: 30474008
[TBL] [Abstract][Full Text] [Related]
15. Antiapoptotic properties of MALT1 protease are associated with redox homeostasis in ABC-DLBCL cells.
Zhu L; Tang F; Lei Z; Guo C; Song Y; Huang J; Xia X
Mol Carcinog; 2019 Dec; 58(12):2340-2352. PubMed ID: 31556968
[TBL] [Abstract][Full Text] [Related]
16. [Detection of API2-MALT1 fusion gene in extranodal B-cell lymphoma and its significance].
Yang WX; Li GD; Zhou Q; Liu WP; Li L; Chen N
Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):92-6. PubMed ID: 16630483
[TBL] [Abstract][Full Text] [Related]
17. Changes in the MALT1-A20-NF-κB expression pattern may be related to T cell dysfunction in AML.
Shi L; Chen S; Lu Y; Wang X; Xu L; Zhang F; Yang L; Wu X; Li B; Li Y
Cancer Cell Int; 2013 Apr; 13(1):37. PubMed ID: 23627638
[TBL] [Abstract][Full Text] [Related]
18. Low dose of lenalidmide and PI3K/mTOR inhibitor trigger synergistic cytoxicity in activated B cell-like subtype of diffuse large B cell lymphoma.
Jin Z; Qing K; Ouyang Y; Liu Z; Wang W; Li X; Xu Z; Li J
J Exp Clin Cancer Res; 2016 Mar; 35():52. PubMed ID: 27009084
[TBL] [Abstract][Full Text] [Related]
19. MALT1 inhibitors prevent the development of DSS-induced experimental colitis in mice via inhibiting NF-κB and NLRP3 inflammasome activation.
Liu W; Guo W; Hang N; Yang Y; Wu X; Shen Y; Cao J; Sun Y; Xu Q
Oncotarget; 2016 May; 7(21):30536-49. PubMed ID: 27105502
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-181a Inhibits Activated B-Cell-Like Diffuse Large B-Cell Lymphoma Progression by Repressing
Zhu D; Fang C; He W; Wu C; Li X; Wu J
J Oncol; 2019; 2019():9832956. PubMed ID: 31662757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
